National Immunization Survey-Teen (NIS-Teen) 2020, Texas
Immunization Coverage Among Texas Teens 13-17 Years Old
Source: CDC NIS-Teen Report
About the National Immunization Survey-Teen (NIS-Teen)
The NIS-Teen is a national survey conducted every year by the Centers for Disease Control and Prevention (CDC) to assess vaccination coverage levels, or the percentage of people vaccinated, among adolescents 13-17 years of age. This study collects data by interviewing households in all 50 states, the District of Columbia, and smaller selected areas. The interviews are conducted by telephone, with households selected at random. To ensure the accuracy of vaccination coverage estimates, participant vaccination records are collected from healthcare providers by mail after the interview. The parents and guardians of eligible teens are asked during the telephone interview for consent to contact the adolescents’ vaccination providers to verify their records.
The NIS-Teen was established to provide an ongoing and consistent data set for analyzing vaccination coverage levels among adolescents in the United States and to share this information with interested public health partners. The NIS-Teen provides national and statewide estimates of vaccination coverage, including new vaccines as they are licensed and recommended for use. It also helps track progress towards the Healthy People 2030 goals.
Survey Sample
The survey assessed the vaccination histories of approximately 20,000 U.S. adolescents aged 13-17 years between January 2020 and February 2021. These adolescents were born between January 2002 and February 2008. A total of 1,141 Texas teens were interviewed as part of this study, with estimated vaccination coverage levels for the state of Texas and two local Texas areas – the City of Houston and Bexar County.
Vaccines Included
The following vaccine doses routinely recommended for adolescents starting at 11-12 years of age, were measured in the 2020 NIS-Teen:
- ≥1 dose of Tetanus-diphtheria-pertussis (Tdap) vaccine
- ≥1 dose of Quadrivalent Meningococcal Conjugate (MenACWY) vaccine
- ≥1 dose of human papillomavirus (HPV) vaccine
- HPV vaccine, Up-to-Date, either two or three doses dependent on age of initiation
- Hepatitis A (HepA) vaccination, newly added to the NIS-Teen survey for 2020. In July 2020, Advisory Committee on Immunization Practices (ACIP) revised recommendations for HepA vaccination to include catch-up vaccination for children and adolescents aged 2–18 years who have not previously received HepA vaccine.
Vaccination Coverage Levels
| Vaccine | U.S. 2020 | Texas 2019 | Texas 2020 |
2019 to 2020 Texas |
|---|---|---|---|---|
| ≥1 dose of tetanus-diphtheria-acellular pertussis (Tdap) | 90.1% | 84.8% | 84%c | -0.8% |
| ≥1 dose of meningococcal conjugate (MenACWY) | 89.3% | 85.9% | 91.2% | 5.3%b |
| ≥1 dose of human papillomavirus (HPV) | 75.1% | 65.1% | 72.8%% | 7.7% b |
| HPV Up-To-Date (HPV UTD) | 58.6% | 48.4% | 54.9% | 6.5% b |
| ≥1 dose of HPV, females | 77.1% | 64.2% | 76.1% | 11.9%b |
| HPV UTD, females | 61.4% | 50.6% | 57.0% | 6.4% |
| ≥1 of HPV, males | 73.1% | 65.9% | 69.6% | 3.8% |
| HPV UTD, males | 56.0% | 46.3% | 52.9% | 6.6% |
| ≥2 doses of measles, mumps, rubella (MMR) | 92.4% | 84.2% | 85.9% c | 1.7% |
| ≥2 doses of varicella (VAR) | 91.9% | 81.6% | 86.7%c | 5.1% b |
| ≥2 HepA | 82.1% | 81.4% | 87.1%a | 5.7% b |
a Significantly greater (p<.0.05) than the U.S. estimate
b Statistically significant difference (p<0.05) between years
c Significantly lower (p<0.05) than the U.S. estimate
View accessible data table of chart below:
| Vaccine | U.S. | Texas | City of Houston | Bexar County |
|---|---|---|---|---|
| ≥1 Tdap | 90.1% | 84% | 87.6% | 87.2% |
| ≥1 MenACWY | 89.3% | 91.2% | 89.2% | 90.6% |
View accessible data table of chart below:
| Vaccine | U.S. | Texas | City of Houston | Bexar County |
|---|---|---|---|---|
| ≥1 HPV, females | 77.1% | 76.1% | 87.6% | 77.2% |
| HPV UTD, females | 61.4% | 57% | 72.5% | 62.1% |
| ≥1 HPV, males | 71.3% | 69.6% | 67% | 74.2% |
| HPV UTD, males | 56.% | 52.9% | 49.8% | 59.4% |
a The same methodology was not used for all years.
View accessible data table of chart below:
| Demographics | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| U.S, Female | 53.0% | 53.8% | 56.7% | 60.0% | 62.8% | 65.1% | 68.6% | 69.9% | 73.2% | 77.1% |
| Texas, Female | 48.8% | 51.2% | 55.5% | 50.7% | 60.1% | 54.5% | 60.4% | 64.6% | 64.2% | 73.1% |
| U.S, Male | 8.3% | 20.8% | 33.6% | 41.7% | 49.8% | 56.0% | 62.6% | 66.3% | 69.8% | 73.1% |
| Texas, Male | 10.4% | 24.0% | 33.7% | 36.6% | 41.4% | 44.3% | 55.2% | 55.5% | 65.9% | 69.6% |
a The same methodology was not used for all years.
Previous Years Survey Results
2019 National Immunization Survey Results
2018 National Immunization Survey Results
2017 National Immunization Survey Results
2016 National Immunization Survey Results
2015 National Immunization Survey Results
2014 National Immunization Survey Results
2013 National Immunization Survey Results
2010 National Immunization Survey Results
2009 National Immunization Survey Results
2008 National Immunization Survey Results
2007 National Immunization Survey Results
2006 National Immunization Survey Results
2005 National Immunization Survey Results
2004 National Immunization Survey Results
2003 National Immunization Survey Results
2002 National Immunization Survey Results